HeraMED Ltd

Healthcare AU HMD


Last update at 2024-05-29T00:04:00Z

Day Range


52 Week Range



Income Statement


Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -4.88066M -5.70894M -3.35897M -3.24704M -3.76648M
Minority interest - - - - -
Net income -6.61857M -7.38291M -3.45822M -3.32376M -3.76648M
Selling general administrative 1.71M 1.73M 1.16M 1.24M 1.81M
Selling and marketing expenses 0.50M 0.46M 0.86M 0.98M 0.32M
Gross profit 0.14M 0.04M 0.00793M 0.03M -0.05690M
Reconciled depreciation 0.36M 0.27M 0.34M 0.35M 0.30M
Ebit -3.14275M -3.93894M -3.34864M -3.23959M -2.87490M
Ebitda -2.78434M -3.66724M -3.08997M -2.99670M -2.57974M
Depreciation and amortization 0.36M 0.27M 0.26M 0.24M 0.30M
Non operating income net other - - - - -
Operating income -3.14275M -3.93894M -3.34864M -3.23959M -2.87490M
Other operating expenses 3.40M 4.03M 3.49M 3.49M 2.95M
Interest expense 1.74M 1.67M 0.01M 0.00745M 0.89M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.04M 1.67M 0.00312M 0.03M 0.04M
Net interest income -1.69978M -1.67389M 0.00405M 0.04M -1.26322M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.74M 1.67M 0.10M 0.08M 0.00000M
Total revenue 0.22M 0.09M 0.04M 0.15M 0.08M
Total operating expenses 3.32M 3.98M 3.46M 3.38M 2.82M
Cost of revenue 0.08M 0.04M 0.03M 0.11M 0.13M
Total other income expense net -1.73791M -1.77001M -0.01033M -0.00745M -0.89158M
Discontinued operations - - - - -
Net income from continuing ops -4.88066M -5.70894M -4.36116M -4.46601M -5.33647M
Net income applicable to common shares -4.88066M -5.70894M -3.35897M -3.12888M -3.76648M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 2.95M 4.16M 4.59M 3.19M 3.60M
Intangible assets - 1.04M 0.67M 0.97M 1.16M
Earning assets - - - - -
Other current assets - - 0.04M 0.10M 0.12M
Total liab 2.27M 1.30M 4.70M 1.20M 1.22M
Total stockholder equity 0.68M 2.86M -0.10598M 2.00M 2.39M
Deferred long term liab - 1.04M 0.67M 0.87M 1.06M
Other current liab 0.05M 0.05M 0.03M 0.01M 0.02M
Common stock 35.33M 22.16M 16.48M 13.38M 10.79M
Capital stock - 22.16M 16.48M 13.38M 10.79M
Retained earnings -42.12226M -24.23935M -19.35869M -13.64975M -10.40894M
Other liab - 0.50M 0.55M 0.49M 0.50M
Good will - - - - -
Other assets 0.00000M 1.04M 0.67M 0.87M 1.06M
Cash 1.06M 2.62M 3.56M 1.90M 2.05M
Cash and equivalents - - - - -
Total current liabilities 1.51M 0.79M 4.15M 0.52M 0.54M
Current deferred revenue 0.00000M - - - -
Net debt -0.79935M -2.43849M -0.14091M -1.71230M -1.80453M
Short term debt 0.26M 0.18M 3.42M 0.00581M 0.07M
Short long term debt - 0.18M 3.42M - -
Short long term debt total 0.26M 0.18M 3.42M 0.19M 0.24M
Other stockholder equity 0.00000M 0.09M 2.77M 2.27M 0.12M
Property plant equipment - 0.08M 0.03M 0.02M 0.09M
Total current assets 1.93M 3.04M 3.89M 2.21M 2.36M
Long term investments - - - - -
Net tangible assets - 2.86M -0.77634M 1.90M 2.29M
Short term investments - 0.02M 0.03M - -
Net receivables 0.50M 0.25M 0.24M 0.23M 0.14M
Long term debt - - 0.00000M 0.19M 0.17M
Inventory 0.36M 0.17M 0.09M 0.07M 0.06M
Accounts payable 1.20M 0.56M 0.69M 0.50M 0.46M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 7.47M 4.94M 2.77M 2.27M 1.89M
Additional paid in capital - - - - -
Common stock total equity - - - 17.37M 15.40M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.95M - 0.00000M 0.00000M 0.00000M
Deferred long term asset charges - - - - -
Non current assets total 1.03M 1.11M 0.70M 0.99M 1.25M
Capital lease obligations - - - 0.00754M 0.10M
Long term debt total - 0.00000M 0.00000M 0.19M 0.17M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.69078M -0.08543M -0.07588M -0.29578M -0.24606M
Change to liabilities 0.00000M 0.19M 0.04M -0.01418M 0.04M
Total cashflows from investing activities -0.69078M -0.08543M -0.06731M -0.20722M -0.17367M
Net borrowings -0.10290M 1.69M -0.10534M -0.08128M 1.48M
Total cash from financing activities 2.54M 4.88M 2.52M 0.82M 8.45M
Change to operating activities - - - 0.05M 0.01M
Net income -6.61857M -5.70894M -3.35897M -3.12888M -3.76648M
Change in cash -0.94238M 1.66M -0.14166M -1.98822M 5.65M
Begin period cash flow 3.56M 1.90M 2.05M 4.03M 0.06M
End period cash flow 2.62M 3.56M 1.90M 2.05M 5.72M
Total cash from operating activities -6.26016M -3.23179M -2.78807M -2.72687M -1.76615M
Issuance of capital stock 2.64M 3.31M 2.62M 0.92M 4.49M
Depreciation 0.36M 0.27M 0.34M 0.35M 0.30M
Other cashflows from investing activities - - - - 0.00427M
Dividends paid - - - - -
Change to inventory - -0.01922M -0.01118M 0.05M -0.04174M
Change to account receivables - -0.00840M 0.02M -0.07742M -0.16239M
Sale purchase of stock 2.64M 3.31M 2.62M 0.92M 4.49M
Other cashflows from financing activities -0.10290M 1.69M -0.10534M -0.09222M 2.31M
Change to netincome - 2.21M 0.27M 0.28M 1.94M
Capital expenditures 0.69M 0.09M 0.06M 0.21M 0.00716M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.02M 0.00048M 0.00594M 0.01M 0.00088M
Stock based compensation - - - - -
Other non cash items 6.26M 5.44M 3.02M 2.78M 3.47M
Free cash flow -6.95094M -3.31721M -2.84651M -2.93409M -2.50949M


  • Previous Close 0.02
  • Market Cap6.69M
  • Volume80000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.38113M
  • Revenue TTM0.40M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM 0.14M
  • Diluted EPS TTM-0.03

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
HeraMED Ltd
-0.001 5.56% 0.02 - - 14.91 8.62 13.26 -1.3453
Cochlear Ltd
-12.31 3.79% 312.61 60.26 46.30 9.75 11.76 9.62 36.63
Polynovo Ltd
0.04 1.90% 2.15 - 140.85 17.37 21.49 17.51 647.42
Anteris Technologies Ltd
-0.2 1.04% 19.00 - - 104.23 14.98 95.15 -5.9152
Avita Therapeutics Inc
0.17 6.75% 2.69 - - 8.59 5.71 6.72 -10.0538

Reports Covered

Stock Research & News


HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. It also provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a cloud-based remote maternity care platform. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is based in Netanya, Israel.

HeraMED Ltd

4 Hazoran Street, Netanya, Israel, 4250604

Key Executives

Name Title Year Born
Mr. David Groberman Co-Founder, CEO & Exec. Director NA
Mr. Tal Slonim Co-Founder, COO & Exec. Director NA
Ms. Sivan Sadan Chief Financial Officer NA
Mr. Michael Nenner Chief Technology Officer NA
Henry Jordan Head of Investor Relations NA
Mr. Ariel Laden VP of Marketing NA
Dr. Josef Tovbin Chief Medical Officer NA
Mr. Jonathan Hart B.Com., L.L.B. Company Sec. NA
Dr. Ronald Peter Weinberger AIMM, BSc (Hons), Ph.D. Executive Chairman NA
Dr. Ronald Peter Weinberger AIMM, BSc (Hons), Ph.D. Executive Chairman NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).